SOPHiA GENETICS supports The University of Maryland Medical Center to advance their rare disease research BOSTON & LAUSANNE, Switzerland --(BUSINESS WIRE)--Apr. 18, 2023-- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space and a leader in data-driven medicine,
